Genprex Other Current Liab from 2010 to 2024

GNPX Stock  USD 1.16  0.10  9.43%   
Genprex Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities is likely to outpace its year average in 2024. During the period from 2010 to 2024, Genprex Other Current Liabilities regression line of annual values had r-squared of  0.61 and arithmetic mean of  581,349. View All Fundamentals
 
Other Current Liabilities  
First Reported
2016-12-31
Previous Quarter
1.1 M
Current Value
938.2 K
Quarterly Volatility
817.9 K
 
Covid
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Interest Expense of 21.9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.61. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
  
Check out the analysis of Genprex Correlation against competitors.
For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Latest Genprex's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Genprex over the last few years. It is Genprex's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genprex's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Genprex Other Current Liab Regression Statistics

Arithmetic Mean581,349
Geometric Mean141,220
Coefficient Of Variation139.08
Mean Deviation627,961
Median257,756
Standard Deviation808,565
Sample Variance653.8B
Range2.4M
R-Value0.78
Mean Square Error272.1B
R-Squared0.61
Significance0.0006
Slope141,620
Total Sum of Squares9.2T

Genprex Other Current Liab History

20241.9 M
20231.9 M
20222.4 M
2021612.1 K
2020257.8 K
201974.4 K
2018387.8 K

About Genprex Financial Statements

Genprex investors use historical fundamental indicators, such as Genprex's Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genprex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities1.9 M1.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.